(Q34372874)

1 August 2017

0 references

1 reference

title

Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin (English)

1 reference

1 August 2017

1 reference

1 reference

1

Celeste Leigh Pearce

1 reference

1 August 2017

4

Anna H Wu

1 reference

1 August 2017

Karine Chung

2

1 reference

PubMed ID

19127543

1 August 2017

Malcolm C Pike

series ordinal

3

1 reference

PubMed ID

19127543

1 August 2017

language of work or name

English

0 references

publication date

1 February 2009

1 reference

1 August 2017

1 reference

1 August 2017

115

1 reference

1 August 2017

3

1 reference

1 August 2017

531-539

1 reference

Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis

1 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203480

Ovarian cancer and hormone replacement therapy in the Million Women Study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203480

A prospective study of postmenopausal hormone use and ovarian cancer risk

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203480

An overview of menopausal oestrogen-progestin hormone therapy and breast cancer risk

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203480

Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203480

Menstrual and reproductive factors in relation to ovarian cancer risk.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203480

Hormone replacement therapy and risk of epithelial ovarian cancer.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203480

Bias in meta-analysis detected by a simple, graphical test

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203480

Factors in the causation and incidence of ovarian cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203480

Methods for Trend Estimation from Summarized Dose-Response Data, with Applications to Meta-Analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203480

A case control study of carcinoma of the ovary

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203480

Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCNCR.23956

Effect of reproductive hormones on ovarian epithelial tumors: I. Effect on cell cycle activity

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCNCR.23956

Menopausal hormone therapy and risk of epithelial ovarian cancer

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203480

Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203480

Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203480

Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203480

Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203480

Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203480

Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203480

Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203480

Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203480

Risk Factors for Epithelial Borderline Ovarian Tumors: Results of a Swedish Case–Control Study

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203480

Hormone Therapy and the Impact of Estrogen Intake on the Risk of Ovarian Cancer

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203480

Noncontraceptive estrogen use and the occurrence of ovarian cancer

9 December 2018

1 reference

12 December 2020

Prescribing of noncontraceptive estrogens and progestins in the United States, 1974-86

1 reference

12 December 2020

Physical activity, waist-to-hip ratio, and other risk factors for ovarian cancer: a follow-up study of older women

1 reference

12 December 2020

Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort

1 reference

12 December 2020

Estrogen replacement therapy and risk of epithelial ovarian cancer

1 reference

12 December 2020

Effect of progestin on the ovarian epithelium of macaques: cancer prevention through apoptosis?

1 reference

12 December 2020

Pregnancy recency and risk of ovarian cancer

1 reference

12 December 2020

Hormone replacement therapy and invasive and borderline epithelial ovarian cancer risk

1 reference

12 December 2020

Risk of cancer in women receiving hormone replacement therapy

1 reference

12 December 2020

Estrogen replacement therapy and ovarian cancer

1 reference

12 December 2020

Menopausal hormones and risk of ovarian cancer

1 reference

12 December 2020

Oral contraceptives and ovarian cancer

1 reference

12 December 2020

Menopausal hormone replacement therapy and risk of ovarian cancer

1 reference

12 December 2020

Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone

1 reference

12 December 2020

Determinants of ovarian cancer risk. I. Reproductive experiences and family history

1 reference

12 December 2020

Incidence of cancer among women using long versus monthly cycle hormonal replacement therapy, Finland 1994-1997

1 reference

12 December 2020

Identifiers

DOI

10.1002/CNCR.23956

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

PubMed ID

19127543